You have 6 free searches left this month | for more free features.

stage II pancreatic cancer

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer Trial in United

Active, not recruiting
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Fairfield, Connecticut
  • +8 more
Oct 31, 2022

Borderline Resectable Pancreatic Carcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Resectable Pancreatic

Recruiting
  • Borderline Resectable Pancreatic Carcinoma
  • +8 more
  • Portland, Oregon
    OHSU Knight Cancer Institute
Aug 25, 2022

Acute Myeloid Leukemia, Brain Glioblastoma, Estrogen Receptor Negative Trial in Fullerton (Best Practice, Laboratory Biomarker

Active, not recruiting
  • Acute Myeloid Leukemia
  • +66 more
  • Best Practice
  • +3 more
  • Fullerton, California
    Virginia K Crosson Cancer Center
Jan 31, 2022

Head and Neck Squamous Cell Carcinoma, Metastatic Pancreatic Adenocarcinoma, Non-Resectable Cholangiocarcinoma Trial in Los

Active, not recruiting
  • Head and Neck Squamous Cell Carcinoma
  • +15 more
  • Los Angeles, California
  • +1 more
Aug 5, 2022

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • sorafenib tosylate
  • +4 more
  • Aurora, Colorado
  • +1 more
Sep 8, 2022

Pancreatic Ductal Adenocarcinoma, Colorectal Adenocarcinoma, Gastric Adenocarcinoma Trial in Philadelphia (Adenovirus

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • +37 more
  • Adenovirus 5/F35-Human Guanylyl Cyclase C-PADRE
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Nov 2, 2021

Locally Advanced Malignant Solid Tumor, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in United

Recruiting
  • Locally Advanced Malignant Solid Neoplasm
  • +3 more
  • Agonistic Anti-OX40 Monoclonal Antibody INCAGN01949
  • VLP-encapsulated TLR9 Agonist CMP-001
  • Scottsdale, Arizona
  • +3 more
Jun 1, 2022

Locally Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma Trial in

Active, not recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +4 more
  • Biopsy
  • +4 more
  • Chicago, Illinois
  • +11 more
Jun 28, 2022

Locally Advanced Pancreatic Adenocarcinoma, Locally Advanced Unresectable Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer

Recruiting
  • Locally Advanced Pancreatic Adenocarcinoma
  • +6 more
  • Hypofractionated Radiation Therapy
  • +2 more
  • Duarte, California
  • +29 more
Apr 2, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage II Pancreatic Cancer AJCC v8 Trial in Canada,

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +5 more
  • Anetumab Ravtansine
  • +5 more
  • Birmingham, Alabama
  • +44 more
Feb 2, 2023

Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta (Siltuximab, Spartalizumab)

Recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • Stage IV Pancreatic Cancer AJCC v8
  • Siltuximab
  • Spartalizumab
  • Atlanta, Georgia
  • +2 more
Feb 1, 2022

Advanced Pancreatic Adenocarcinoma, Metastatic Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v8 Trial in Atlanta

Recruiting
  • Advanced Pancreatic Adenocarcinoma
  • +2 more
  • Atlanta, Georgia
  • +2 more
Feb 28, 2022

Pancreatic Cancer Trial run by the (ipilimumab)

Completed
  • Pancreatic Cancer
  • ipilimumab
  • Bethesda, Maryland
  • +1 more
Sep 24, 2021

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Stage IV Pancreatic Cancer Trial in

Suspended
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +4 more
  • Detroit, Michigan
  • +1 more
Feb 2, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Carcinoma, Stage III Pancreatic Cancer Trial in Detroit (biological,

Completed
  • Metastatic Pancreatic Adenocarcinoma
  • +3 more
  • Aldesleukin
  • +9 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8, Stage IV Pancreatic Cancer AJCC v8, Unresectable

Recruiting
  • Stage III Pancreatic Cancer American Joint Committee on Cancer (AJCC) v8
  • +2 more
  • Best Practice
  • +5 more
  • Los Angeles, California
    UCLA / Jonsson Comprehensive Cancer Center
Oct 13, 2023

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in Bronx

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +4 more
  • Bronx, New York
    Montefiore Medical Center
May 18, 2021

Pancreatic Cancer Stage IV, Chemo-induced Nausea and Vomiting Trial (Thalidomide, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Pancreatic Cancer Stage IV
  • Chemotherapy-induced Nausea and Vomiting
  • (no location specified)
Aug 24, 2023

Acinar Cell Adenocarcinoma of the Pancreas, Duct Cell Adenocarcinoma of the Pancreas, Recurrent Pancreatic Cancer Trial in

Completed
  • Acinar Cell Adenocarcinoma of the Pancreas
  • +3 more
  • metformin hydrochloride
  • +4 more
  • Cleveland, Ohio
  • +1 more
Aug 9, 2021

Metastatic Pancreatic Cancer, Terminal Cancer Trial in Shanghai (Ascorbate)

Recruiting
  • Metastatic Pancreatic Cancer
  • Terminal Cancer
  • Shanghai, Shanghai, China
    Shanghai Cancer Center
Aug 29, 2023

Metastatic Pancreatic Cancer Trial in Singapore (Low Dose OXIRI (LD-OXIRI))

Not yet recruiting
  • Metastatic Pancreatic Cancer
  • Low Dose OXIRI (LD-OXIRI)
  • Singapore, Singapore
    National Cancer Centre, Singapore
Jun 29, 2023

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (gemcitabine HCl,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • gemcitabine hydrochloride
  • +3 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020

Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer Trial in Philadelphia (drug, radiation,

Completed
  • Adenocarcinoma of the Pancreas
  • +2 more
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 29, 2020